An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma
Cell Death & Disease
Open Access Publication
Rights and Permissions
Darawshi, O., Muz, B., Naamat, S.G. et al. An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma. Cell Death Dis 13, 969 (2022). https://doi.org/10.1038/s41419-022-05421-4 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Darawshi, Odai; Muz, Barbara; and et al., "An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma." Cell Death & Disease. 13, 11. 969 (2022).
Supplemental material is available for this article at publisher site.